Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

VYNE Therapeutics Launches Phase 2b Clinical Trial for VYN201, a New BET Inhibitor in Vitiligo Research

Thursday, June 06, 2024

VYNE Therapeutics Inc is advancing in its clinical research aimed at developing new treatments for conditions involving immune system inflammation The company has launched a Phase b clinical trial

Syngene Introduces Innovative Platform for Quick and Enhanced Protein Production

Wednesday, June 05, 2024

Syngene International Ltd has recently introduced its latest protein production platform integrating cell line and transposonbased technology from ExcellGene a Swiss biotech services company

BioVersys Secures Non-Dilutive Funding from CF AMR Syndicate Collaborative Discovery Programme

Wednesday, June 05, 2024

BioVersys AG a clinicalstage biopharmaceutical company has announced the reception of a nondilutive award from the CF AMR Syndicate totaling up to The award facilitated through the LifeArc funded

Spruce Biosciences and HMNC Brain Health Team Up to Develop Innovative Treatment for Major Depressive Disorder (MDD)

Wednesday, June 05, 2024

Spruce Biosciences Inc a biopharmaceutical company specializing in advanced therapies for endocrine and neurological disorders and HMNC Brain Health GmbH a global leader in precision psychiatry

QIAGEN Enhances Syndromic Testing in Malaysia with MDA Approval of Advanced QIAstat-Dx Respiratory Panel

Tuesday, June 04, 2024

QIAGEN has introduced an improved version of its QIAstatDx Respiratory SARSCoV Panel in Malaysia following approval by the Medical Device Authority This new version which holds a CEIVD mark

7 Hills Pharma Secures $4.7 Million Grant to Advance First-of-Its-Kind Cell/Gene Therapy Technology into Clinical Trials

Tuesday, June 04, 2024

Hills Pharma Inc a clinicalstage pharmaceutical company has been granted million by the Cancer Prevention and Research Institute of Texas to bolster its cellgene therapy development program

Eisai Boosts Venture Investment Focus to Drive Drug Discovery Innovation and Foster Ecosystem Platform

Tuesday, June 04, 2024

Eisai Co Ltd headquartered in Tokyo and led by CEO Haruo Naito has announced plans to reinforce and continue its venture investment business which was initiated in

FDA Approves Moderna's RSV Vaccine, mRESVIA(R)

Monday, June 03, 2024

Moderna Inc has received approval from the US Food and Drug Administration for mRESVIA an mRNA vaccine designed to combat respiratory syncytial virus in adults aged years and older This breakthrough therapy designation marks Modernas second mRNA pr...

Invivyd and U.S. FDA Collaborate on Streamlined Path for COVID-19 Prevention and Treatment with Serial Monoclonal Antibodies

Monday, June 03, 2024

Invivyd Inc a biopharmaceutical company specializing in combating severe viral infectious diseases has revealed an accord with the US Food and Drug Administration regarding a streamlined

EMA Grants Orphan Drug Status to SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung Cancer

Saturday, June 01, 2024

SN Bioscience Co Ltd announced on May that the European Medicines Agency has granted orphan drug designation to SNB for the treatment of small cell lung cancer